Abstract
A 54-year-old woman with metastatic colorectal carcinoma underwent liver radioembolization with 90Y resin microspheres. Microsphere biodistribution was assessed 2 h after the treatment through a 20-min long 90Y PET scan. Isodose map and lesion dose–volume histogram (DVH) were then evaluated using a MATLAB-based code. Response to therapy was assessed performing a 18F-FDG PET 6 months after the treatment. At 90Y PET the patient showed a well-defined horseshoe-shaped hepatic lesion with hot margins and a cold core. The lesion presented a heterogeneous DVH with a hot margin receiving an average radiation dose as high as 287 Gy and a cold area receiving an average radiation dose of 70 Gy approximately. Six months after the treatment the patient reported a complete remission of tumour areas which received a high radiation dose, while progression of metastases was observed in the area that presented scarce microsphere localization at 90Y PET. According to our experience, the use of 90Y PET voxel dosimetry may provide a useful tool to assess possible correlations between microsphere biodistribution and clinical outcome of the treatment. In agreement with current literature findings, an average radiation dose greater than approximately 100 Gy may be required to sterilize liver metastases.
Similar content being viewed by others
References
Selwyn RG, Nickles RJ, Thomadsen BR, DeWerd LA, Micka JA. A new internal pair production branching ratio of 90Y: the development of a non-destructive assay for 90Y and 90Sr. Appl Radiat Isot. 2007;65:318–27.
Lhommel R, van Elmbt L, Goffette P, Van den Eynde M, Jamar F, Pauwels S, et al. Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres. Eur J Nucl Med Mol Imaging. 2010;37:1654–62.
Werner MK, Brechtel K, Beyer T, Dittmann H, Pfannenberg C, Kupfershlager J. PET/CT for the assessment and quantification of 90Y biodistribution after selective internal radiotherapy (SIRT) of liver metastases. Eur J Nucl Med Mol Imaging. 2010;37:407–8.
Gates VL, Esmail AA, Marshall K, Spies S, Salem R. Internal pair production of 90Y permits hepatic localization of microspheres using routine PET: proof of concept. J Nucl Med. 2011;52:72–6.
Bagni O, D’Arienzo M, Chiaramida P, Chiacchiarelli L, Cannas P, D’Agostini A, Cianni R, Salvatori R, Scopinaro F. 90Y PET for the assessment of microsphere biodistribution after selective internal radiotherapy. Nucl Med Commun. 2012;33:198–204.
D’Arienzo M, Chiaramida P, Chiacchiarelli L, Coniglio A, Cianni R, Salvatori R, et al. 90Y PET-based dosimetry after selective internal radiotherapy treatments. Nucl Med Commun. 2012;33:633–40.
Willowson K, Forwood N, Jakoby BW, Smith AM, Bailey DL. Quantitative 90Y image reconstruction in PET. Med Phys. 2012;39:7153–9.
Goin JE, Dancey JE, Hermamm GA, Sickles CJ, Roberts CA, MacDonald JS. Treatment of unresectable metastatic colorectal carcinoma to the liver with intrahepatic Y-90 microspheres: a dose-ranging study. World J Nucl Med. 2003;2:216–25.
Kao YH, Tan AEH, Burgmans MK, Irani FG, Khoo LS. Gong Lo RH, et al. Image guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization. J Nucl Med. 2012;53:559–66.
Lewandowski R, Thurston K, Goin J, Wong CY, Gates VL, Van Buskirk M, et al. 90Y microsphere (TheraSphere), treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135–150 Gy as measured by [18F] fluorodeoxyglucose positron emission tomography and computed tomographic imaging. J Vasc Interv Radiol. 2005;16:1641–51.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
D’Arienzo, M., Filippi, L., Chiaramida, P. et al. Absorbed dose to lesion and clinical outcome after liver radioembolization with 90Y microspheres: a case report of PET-based dosimetry. Ann Nucl Med 27, 676–680 (2013). https://doi.org/10.1007/s12149-013-0726-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12149-013-0726-4